Metformin use is linked to a lower risk of hospitalization for heart failure in patients with type 2 diabetes, a paper in the Journal of the American Heart Association confirms.

A study of patients undergoing catheter ablation of atrial fibrillation between 2010 and 2015 found that early post-ablation mortality rates increased over the half-decade, reaching 1.35% per quarter by the end of the research period.

Finalized results from the OSLER-1 trial—the longest-running study of PCSK9 inhibitors to date—suggest evolocumab is safe and “consistently excellent” at lowering LDL-cholesterol through five years.

Hackensack University Medical Center is the first practice in the U.S. to successfully perform heart surgeries using Abiomed’s Impella 5.5 LVAD.

Facebook introduced a new tool this week that provides the platform’s users with personalized healthcare recommendations, CNN reports.

Bulimia nervosa places women at a significantly greater risk of CVB and death than women who have not been diagnosed with the condition, a JAMA Psychiatry study reveals.

Cardiac care is suffering at hospitals that experience data breaches, PBS reported Oct. 24, with one study finding that heart attack rates soar in the weeks and months after a center’s cybersecurity is compromised.

The risks of treating pre-hypertension, pre-diabetes, and similar conditions may outweigh the benefits of doing so, according to Consumer Reports.